CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 37,500 shares (grant or award)
- 4 Grant or award Director acquired 45,455 shares (grant or award)
- 4 Open-market buy Director bought 34,848 shares
- 4 Open-market sale Director sold 30,000 shares at $1.00 ($30,000)
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.57 ($14,250)
- 4 Open-market buy Chief Financial Officer bought 75,000 shares at $0.61 ($45,750)
- 4 Open-market sale Director sold 23,400 shares at an average $0.50 ($11,812)
- 4 Grant or award Director acquired 27,871 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President & CEO bought 97,000 shares at $0.52 ($50,440)
- 4 Open-market buy President and CEO bought 19,100 shares at $0.51 ($9,741)
- 4 Open-market buy Chief Financial Officer bought 100,000 shares at $0.52 ($52,000)
- 4 Conversion 10% owner acquired 792,200 shares (conversion)
- 4 Conversion 10% owner acquired 3,961,900 shares (conversion)
- 4 Open-market buy 10% owner bought 2,107,774 shares at $1.00 ($2,107,774)
- 4 Open-market buy 10% owner bought 2,838,090 shares at $1.00 ($2,838,090)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 28 · 551 filings